FLNA overexpression promotes papillary thyroid cancer aggression via the FAK/AKT signaling pathway.
Weiwei LiangYilin ZhangYan GuoPengyuan ZhangJiewen JinHongyu GuanYanbing LiPublished in: Endocrine connections (2024)
FLNA may be regarded as a new therapeutic target for PTC patients.